Back close

Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma

Publication Type : Patents

Publisher : Number 201641018401, India .

Source : Number 201641018401, India (2016)

Campus : Kochi

School : School of Pharmacy

Department : Pharmacognosy

Year : 2016

Abstract : The present invention includes Uttroside B compositions and method for the treatment of hepatocellular carcinoma. Chemotherapeutic options for liver cancer are limited and the prognosis of HCC patients remains dismal. Sorafenib, is the only drug currently available for the treatment of hepatocellular carcinoma.

Cite this Research Publication : Lekshmi R Nath and Anto, R. John, “Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma”, U.S. Patent 2016410184012016.

Admissions Apply Now